ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.675,14
-0,27%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08496
-0,05%
Bitcoin
69.928,18
-0,29%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Australien
  5. ASX
  6. Aeon Metals Limited (AMLN)

  7. Aeon Metals Limited (AMLN) News

AMLN

Aeon Metals (AMLN)

Aeon Metals Limited
Von:
Sortieren nach:
 Showing the most relevant articles for your search:ASX:AMLN
DatumZeitQuelleÜberschriftSymbolFirma
29/10/200913h34Dow Jones NewsUPDATE: Roche's New Diabetes Drug Works Better Than ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
29/10/200910h02Dow Jones NewsRoche: New Diabetes Drug Works Better Than Byetta - StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200923h21Dow Jones News2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200922h17Dow Jones NewsUPDATE: Galleon Holdings Include OSI Pharma, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200922h05Dow Jones NewsGalleon Holdings Include OSI Pharmaceuticals, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
30/09/200912h16Dow Jones NewsNovo Nordisk's Diabetes Drug Victoza Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/08/200914h28Dow Jones NewsNovo Nordisk CEO: Positive Victoza Reception In EuropeNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/07/200923h20Dow Jones NewsAmylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales SlipNASDAQ:AMLNAmylin Pharmaceuticals Inc.
03/07/200913h01Dow Jones NewsUPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU ApprovalNASDAQ:AMLNAmylin Pharmaceuticals Inc.
03/07/200912h06Dow Jones NewsNovo Nordisk's Victoza To Reach Market In A Few Weeks - CSONASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200912h30Dow Jones NewsDoctors Say New Diabetes Drugs Hold Great PromiseNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200909h13Dow Jones NewsCORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200909h12Dow Jones NewsNovo Nordisk Diabetes Drug Liraglutide Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200909h12Dow Jones NewsStudy: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
07/06/200902h00Dow Jones NewsUPDATE: Weekly Diabetes Drug Byetta Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/06/200921h22Dow Jones NewsStudy Shows Weekly Byetta Diabetes Drug Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200919h59Dow Jones NewsUPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead DirNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200919h36Dow Jones NewsAmylin: 2 Dissidents To Replace Chairman, Lead DirectorNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200922h37Dow Jones NewsUPDATE: Amylin: Dissidents Likely Got Up To Two Board SeatsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200922h05Dow Jones NewsEastbourne Claims Success In Electing Directors To Amylin BoardNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/05/200921h02Dow Jones NewsHedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin SlateNASDAQ:AMLNAmylin Pharmaceuticals Inc.
18/05/200914h17Dow Jones NewsMore Proxy Advisers Back Dissidents' Amylin Board NomineesNASDAQ:AMLNAmylin Pharmaceuticals Inc.
16/05/200900h24Dow Jones NewsUPDATE: Risk Metrics Backs Three Dissident Amylin DirectorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
15/05/200923h53Dow Jones NewsRisk Metrics Backs Three Dissident Directors For Amylin BoardNASDAQ:AMLNAmylin Pharmaceuticals Inc.
14/05/200917h13Dow Jones NewsUPDATE: Icahn Fires Back At Amylin Over Latest LetterNASDAQ:AMLNAmylin Pharmaceuticals Inc.
04/05/200923h29Dow Jones NewsAmylin To Trim Sales Team by 35%, Sees $45 Million Savings In '10NASDAQ:AMLNAmylin Pharmaceuticals Inc.
30/04/200920h55Dow Jones NewsDEALWATCH: Lilly Can't Afford To Double Down With AmylinNASDAQ:AMLNAmylin Pharmaceuticals Inc.
28/04/200922h03Dow Jones NewsAmylin Proxy Battle Adds To Debate Over What Makes A 'Group'NASDAQ:AMLNAmylin Pharmaceuticals Inc.
24/04/200911h47Dow Jones NewsUPDATE: Novo Nordisk Has Big Hopes For EU Victoza LaunchNASDAQ:AMLNAmylin Pharmaceuticals Inc.
20/04/200921h01Dow Jones NewsUPDATE: US Drug Stocks Flee Into Negative TerritoryNASDAQ:AMLNAmylin Pharmaceuticals Inc.
 Showing the most relevant articles for your search:ASX:AMLN

Kürzlich von Ihnen besucht

TG
432
Arbor Metals
COIN
SOLUSD
Solana
TG
NOV
Novo Nordisk
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
USOTC
ADDYY
Adidas (QX)
TG
ALV
Allianz
TG
TUI1
Tui
NASDAQ
MSFT
Microsoft
NYSE
KO
Coca Cola
NASDAQ
AMZN
Amazon.com
AMEX
SPY
SPDR S&P 500
FX
EURGBP
Euro vs Sterling
NYSE
MRK
Merck
CCOM
US500
US 500
FX
EURJPY
Euro vs Yen
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten